Showing results (371-380 of 1,149) with videos related to
Sort By:
Pageof 115
Journal of the Peripheral Nervous System : JPNS|June 14, 2018
Clinical and genetic investigation in Chinese patients with demyelinating Charcot-Marie-Tooth diseaseJin He, Lingling Guo, Guorong Xu, et al.Journal of the Peripheral Nervous System : JPNS|December 4, 2003
Effects of gadolinium and tetrodotoxin on the response of slowly adapting type I mechanoreceptors to mechanical stimulation in frog dorsal skinMamoru Takeda, Toshimi Nishikawa, Sumie Sato, et al.Journal of the Peripheral Nervous System : JPNS|February 12, 2004
The role of growth factors in diabetic peripheral neuropathyGina M Leinninger, Andrea M Vincent, Eva L FeldmanJournal of the Peripheral Nervous System : JPNS|June 15, 2007
Nerve conduits and growth factor delivery in peripheral nerve repairLukas A Pfister, Michaël Papaloïzos, Hans P Merkle, et al.Journal of the Peripheral Nervous System : JPNS|June 15, 2007
Immunomodulation by costimulation blockade inhibits rejection of nerve allograftsMartin Kvist, Vasileios Lemplesis, Martin Kanje, et al.Journal of the Peripheral Nervous System : JPNS|July 8, 2008
Novel signals controlling embryonic Schwann cell development, myelination and dedifferentiationRhona Mirsky, Ashwin Woodhoo, David B Parkinson, et al.Journal of the Peripheral Nervous System : JPNS|September 18, 2007
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity ScaleGuido Cavaletti, Barbara Frigeni, Francesca Lanzani, et al.Journal of the Peripheral Nervous System : JPNS|September 18, 2007
Diagnostic role of deep tendon reflex latency measurement in small-fiber neuropathyKhema R Sharma, Daniela Saadia, Alicia G Facca, et al.Journal of the Peripheral Nervous System : JPNS|April 11, 2015
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysisSalvatore Terrazzino, Andreas A Argyriou, Sarah Cargnin, et al.Journal of the Peripheral Nervous System : JPNS|April 29, 2023
An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathyLuis Querol, Richard A Lewis, Hans-Peter Hartung, et al.Pageof 115